These effects are highest during the titration phase, typically peaking around weeks 6-8 of use, and resolve for the majority of participants as the body adapts, usually by week 10-12
Furthermore, HPP971 has completed two phase-I studies for the treatment of several diseases, including blood, bone, eye, kidney, and lung diseases, where it was well tolerated [66]
In rare cases, a rash can appear suddenly after many weeks of stable dosing
Whats next: Final phase 2 data will include results from the maintenance phase (weeks 2652)
conducted in vitro assays
Building Better Habits and Controlling Cravings Sometimes, people turn to microdosing to build better habits, manage their weight during tough times, or break patterns like overeating